The effectiveness of GLP-1 medications will vary from product to product, but most people can expect to see average weight loss results within eight to twelve weeks
So, pharmaceutical companies started investigating the use of GLP-1s for weight-management purposes, and the first GLP-1 weight-loss drug, Saxenda (liraglutide), was approved by FDA in 2014 (it was previously approved to treat diabetes under the name Victoza)
Retatrutide Retatrutide differs from earlier metabolic peptides by simultaneously engaging three distinct G-protein-coupled receptors that regulate energy intake, energy expenditure, and glucose homeostasis
Diabetes Care 34(Supplement_2):S279-84 Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P et al (2019) Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Once you know what the goals are, you can come up with a solid detailed plan on how to get the most benefit with the least side effects
What is more, it seems that GLP-1R agonists may be useful as an adjunctive to traditional therapy to treat cognitive impairments observed in the course of depression, especially in women
